John A. McGrath

33.0k total citations · 2 hit papers
562 papers, 17.0k citations indexed

About

John A. McGrath is a scholar working on Cell Biology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, John A. McGrath has authored 562 papers receiving a total of 17.0k indexed citations (citations by other indexed papers that have themselves been cited), including 379 papers in Cell Biology, 202 papers in Molecular Biology and 139 papers in Pathology and Forensic Medicine. Recurrent topics in John A. McGrath's work include Skin and Cellular Biology Research (356 papers), Autoimmune Bullous Skin Diseases (127 papers) and Cell Adhesion Molecules Research (87 papers). John A. McGrath is often cited by papers focused on Skin and Cellular Biology Research (356 papers), Autoimmune Bullous Skin Diseases (127 papers) and Cell Adhesion Molecules Research (87 papers). John A. McGrath collaborates with scholars based in United Kingdom, United States and Japan. John A. McGrath's co-authors include Jouni Uitto, Robin A.J. Eady, Jemima E. Mellerio, Angela M. Christiano, Joey E. Lai‐Cheong, Akemi Ishida‐Yamamoto, James R. McMillan, Leena Bruckner‐Tuderman, E. Birgitte Lane and Irene M. Leigh and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

John A. McGrath

539 papers receiving 16.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB

2008 598 citations Jo‐David Fine, Robin A.J. Eady et al. Journal of the American Academy of Dermatology profile →
Epidermolysis bullosa

2020 210 citations John A. McGrath, Jemima E. Mellerio et al. profile →

Peers

Countries citing papers authored by John A. McGrath

Since Specialization

Citations

This map shows the geographic impact of John A. McGrath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. McGrath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. McGrath more than expected).

Fields of papers citing papers by John A. McGrath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. McGrath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. McGrath. The network helps show where John A. McGrath may publish in the future.

Co-authorship network of co-authors of John A. McGrath

This figure shows the co-authorship network connecting the top 25 collaborators of John A. McGrath. A scholar is included among the top collaborators of John A. McGrath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. McGrath. John A. McGrath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Costs of UK Community Care for Individuals with Recessive Dystrophic Epidermolysis Bullosa: Findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study 2024 ·SHILAP Revista de lepidopterología ·E. Jeffs, Elizabeth Pillay, (unknown), Alessandra Bisquera, Susan J. Robertson, John A. McGrath, Yanzhong Wang, Anna E. Martinez, Anita Patel, Jemima E. Mellerio	2
2	Real-World Experience of Using Dupilumab and Jak Inhibitors to Manage Pruritus in Epidermolysis Bullosa Pruriginosa 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), John A. McGrath, Chao‐Kai Hsu	3
3	Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa 2024 ·Molecular Therapy ·(unknown), Maral J. Rouhani, Elizabeth Maughan, (unknown), Krishna K. Kolluri, David R. Pearce, (unknown), Liam Sutton, (unknown), (unknown), (unknown), Christopher O’Callaghan, Claire M. Smith, Sam M. Janes, Richard Hewitt, Gabriela Petrof, Anna E. Martinez, John A. McGrath, Colin R. Butler, Robert E. Hynds	3
4	Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin 2024 ·British Journal of Dermatology ·(unknown), (unknown), (unknown), Yu‐Chen Lin, (unknown), (unknown), (unknown), (unknown), Alexandros Onoufriadis, Hans I‐Chen Harn, Daw‐Yang Hwang, Siao Muk Cheng, Kurt Q. Lu, Peng‐Chieh Chen, John A. McGrath, Chao‐Kai Hsu	4
5	Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES) 2024 ·Orphanet Journal of Rare Diseases ·E. Jeffs, Elizabeth Pillay, (unknown), Alessandra Bisquera, Susan J. Robertson, John A. McGrath, Yanzhong Wang, Anna E. Martinez, Jemima E. Mellerio	1
6	ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa 2023 ·Cytotherapy ·(unknown), Elke Niebergall‐Roth, (unknown), (unknown), Natasha Y. Frank, Christoph Ganss, Dimitra Kiritsi, John A. McGrath, Jakub Tolar, Markus H. Frank, Mark A. Kluth	10
7	Topical gene editing therapeutics using lipid nanoparticles: ‘gene creams’ for genetic skin diseases? 2023 ·British Journal of Dermatology ·(unknown), (unknown), Young‐Ah Kim, (unknown), (unknown), Stephen L. Hart, John A. McGrath, J. Jackow	7
8	Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study 2023 ·Orphanet Journal of Rare Diseases ·Jemima E. Mellerio, Elizabeth Pillay, (unknown), Alessandra Bisquera, Susan J. Robertson, (unknown), John A. McGrath, Yanzhong Wang, Anna E. Martinez, E. Jeffs	12
9	Systematic review of the clinical characteristics and natural history of solar urticaria 2023 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), (unknown), (unknown), Hiva Fassihi, Christos Tziotzios, John A. McGrath	6
10	Loss of RhoE Function in Dermatofibroma Promotes Disorganized Dermal Fibroblast Extracellular Matrix and Increased Integrin Activation 2023 ·Journal of Investigative Dermatology ·(unknown), Chao‐Kai Hsu, (unknown), Hsin‐Yu Huang, Yu‐Chen Lin, (unknown), (unknown), Alexandros Onoufriadis, Takuya Takeichi, Julia Yu‐Yun Lee, Tanya J. Shaw, John A. McGrath, Maddy Parsons	2
11	The natural history of laryngo‐onycho‐cutaneous syndrome: A case series of six pediatric patients and literature review 2021 ·Pediatric Dermatology ·Christine Prodinger, (unknown), Jemima E. Mellerio, John A. McGrath, Linda Ozoemena, Lu Liu, William S. Moore, Martin Laimer, Gabriela Petrof, Anna E. Martinez	5
12	Transcriptomic profiling of recessive dystrophic epidermolysis bullosa wounded skin highlights drug repurposing opportunities to improve wound healing 2021 ·Experimental Dermatology ·Alexandros Onoufriadis, Laura E. Proudfoot, Chrysanthi Ainali, Denis Torre, (unknown), (unknown), Ellie Rashidghamat, Retno Danarti, Jemima E. Mellerio, Avi Ma’ayan, John A. McGrath	15
13	Metabolic perturbations in fibrosis disease 2021 ·The International Journal of Biochemistry & Cell Biology ·Chuin Ying Ung, Alexandros Onoufriadis, Maddy Parsons, John A. McGrath, Tanya J. Shaw	37
14	Phase I Study Protocol for Ex Vivo Lentiviral Gene Therapy for the Inherited Skin Disease, Netherton Syndrome 2013 ·PubMed ·Wei‐Li Di, Jemima E. Mellerio, (unknown), John Harper, Alya Abdul‐Wahab, (unknown), Lucas Chan, Magdalena Martinez-Queipo, Havinder Hara, Anne‐Marie McNicol, Farzin Farzaneh, John A. McGrath, Adrian J. Thrasher, Waseem Qasim	27
15	Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa 2012 ·Cancer Research ·(unknown), Céline Pourreyron, Julio C. Salas‐Alanís, Jasbani H.S. Dayal, Rodrigo Cepeda‐Valdes, (unknown), (unknown), Mei Chen, Jo‐David Fine, Fiona J. Hogg, John A. McGrath, Dédée F. Murrell, Irene M. Leigh, (unknown), Andrew P. South	103
16	PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia 2011 ·Proceedings of the National Academy of Sciences ·Katsuto Tamai, Takehiko Yamazaki, Takenao Chino, Masaru Ishii, Satoru Otsuru, Yasushi Kikuchi, Shin Iinuma, Kotaro Saga, Keisuke Nimura, Takashi Shimbo, Noriko Umegaki, Ichiro Katayama, Jun‐ichi Miyazaki, Junji Takeda, John A. McGrath, Jouni Uitto, Yasufumi Kaneda	181
17	Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen 2009 ·Journal of Cell Science ·Vera Martins, (unknown), Mei Chen, Karin J. Purdie, Charles A. Mein, Andrew P. South, Alan Storey, John A. McGrath, Edel A. O’Toole	89
18	Epidermolysis bullosa 2006 ·British Journal of Hospital Medicine ·John A. McGrath, Jemima E. Mellerio	17
19	Heparan sulphate proteoglycan and wound healing in skin 1997 ·The Journal of Pathology ·John A. McGrath, Robin A.J. Eady	15
20	Heparan sulphate proteoglycan and wound healing in skin 1997 ·The Journal of Pathology ·John A. McGrath, Robin A.J. Eady	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact